Innate Pharma announces conference call and webcast for first half 2025 financial results and business update
Number of shares and voting rights of Innate Pharma as of September 1, 2025
Number of shares and voting rights of Innate Pharma as of August 1, 2025
Innate Pharma announces its participation in BTIG virtual biotechnology conference
Number of shares and voting rights of Innate Pharma as of July 3, 2025
Innate Pharma announces its participation in H.C. Wainwright and Wolfe Research Healthcare Conferences
Innate Pharma highlights preclinical antitumor activity of IPH6501 in diffuse large B-cell lymphoma and follicular lymphoma at the 2025 European Hematology Association (EHA) congress
Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences
Outcome of Innate Pharma’s 2025 Annual General Meeting
Innate Pharma highlights durable responses to lacutamab in Sezary syndrome and mycosis fungoides
